Alx Oncology Holdings Inc. · NASDAQ:ALXO
BlackRock, Inc. reported a 5.40% stake in Alx Oncology Holdings Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Jul 27, 2026
BlackRock, Inc. reported a 5.40% stake in Alx Oncology Holdings Inc., 7,327,850 shares, as a passive investor on Jun 30, 2026. Filed Jul 27, 2026 (Schedule 13G).
- Stake
- 5.40%
- Shares
- 7,327,850
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.40% | 7,327,850 |
Source
Related
- Alx Oncology Holdings Inc.
- BlackRock, Inc.
- Alx Oncology Holdings Inc. shareholders
- Schedule 13D/A · venBio Global Strategic Fund, L.P. · Oct 16, 2026
- Form 4 · Lettmann Jason · Aug 18, 2026
- Form 4 · Wong Shelly · Aug 18, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Form 4 · Wong Shelly · Jul 6, 2026